Breast Cancer Vaccine Shows Promise in Study Lead by MD Anderson Cancer Center

(Todd Ackerman, Houston Chronicle)
Houston researchers on Wednesday reported positive results with an experimental breast cancer vaccine, a promising development in an emerging field in cancer care.

The vaccine, one of many now in testing, significantly decreased the recurrence rate of breast cancer in women who had been treated for a common tumor type, according to a study led by the University of Texas M.D. Anderson Cancer Center.

“If this vaccine and others continue to perform well in trials, they could change practice standards in breast cancer,” said Dr. Elizabeth Mittendorf, an M.D. Anderson surgical oncology professor and the study’s principal investigator.

“That’s not to say it will take the place of surgery, chemotherapy or radiation, but it could became incorporated into standard care.” (Read the full story at the Houston Chronicle)

RELATED: Breast Cancer Vaccine Dramatically Reduces Recurrence (KPRC 2 News)



Comments are closed.